Thetford Mines, Quebec – December 21, 2022 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce that it has acquired Covapharm Inc. (“Covapharm”) pursuant to a share purchase agreement (the “Share Purchase Agreement”) dated December 16, 2022, for a consideration of $200,000.00 payable in monthly instalments of $10,000.00 over a period of twenty (20) months from the closing date and a maximum of 1,825,000 Class A shares in the capital stock of the Corporation (the “KDA Shares”).
Learn more